CN103768012A - 一种姜黄素脂质纳米粒悬浮液或纳米粒的制备方法 - Google Patents
一种姜黄素脂质纳米粒悬浮液或纳米粒的制备方法 Download PDFInfo
- Publication number
- CN103768012A CN103768012A CN201310723889.1A CN201310723889A CN103768012A CN 103768012 A CN103768012 A CN 103768012A CN 201310723889 A CN201310723889 A CN 201310723889A CN 103768012 A CN103768012 A CN 103768012A
- Authority
- CN
- China
- Prior art keywords
- phase solution
- curcumin
- aqueous phase
- lipid nanoparticle
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VFLDPWHFBUODDF-FCXRPNKRSA-N Curcumin Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 title claims abstract description 110
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 95
- 239000004148 curcumin Substances 0.000 title claims abstract description 84
- 229940109262 curcumin Drugs 0.000 title claims abstract description 84
- 235000012754 curcumin Nutrition 0.000 title claims abstract description 84
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 title claims abstract description 84
- -1 curcumin lipid Chemical class 0.000 title claims abstract description 60
- 239000000725 suspension Substances 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 24
- 239000012071 phase Substances 0.000 claims abstract description 68
- 239000008346 aqueous phase Substances 0.000 claims abstract description 59
- 238000002360 preparation method Methods 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000003960 organic solvent Substances 0.000 claims abstract description 19
- 229920000642 polymer Polymers 0.000 claims abstract description 14
- 239000004094 surface-active agent Substances 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 229910052756 noble gas Inorganic materials 0.000 claims description 29
- 239000000203 mixture Substances 0.000 claims description 16
- 230000008676 import Effects 0.000 claims description 14
- 229920000762 poly(caprolactone)-poly(ethylene glycol)-poly(caprolactone) Polymers 0.000 claims description 11
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 229920001983 poloxamer Chemical group 0.000 claims description 5
- 238000000703 high-speed centrifugation Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 33
- 229940079593 drug Drugs 0.000 abstract description 17
- 239000002245 particle Substances 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract 4
- 238000005538 encapsulation Methods 0.000 abstract 2
- 239000000243 solution Substances 0.000 description 97
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 238000011068 loading method Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 239000012530 fluid Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 229910021642 ultra pure water Inorganic materials 0.000 description 6
- 239000012498 ultrapure water Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 208000035126 Facies Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229960000502 poloxamer Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002047 solid lipid nanoparticle Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000002122 magnetic nanoparticle Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000005543 nano-size silicon particle Substances 0.000 description 1
- 239000006070 nanosuspension Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 238000001132 ultrasonic dispersion Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310723889.1A CN103768012B (zh) | 2013-12-24 | 2013-12-24 | 一种姜黄素脂质纳米粒悬浮液或纳米粒的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310723889.1A CN103768012B (zh) | 2013-12-24 | 2013-12-24 | 一种姜黄素脂质纳米粒悬浮液或纳米粒的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103768012A true CN103768012A (zh) | 2014-05-07 |
CN103768012B CN103768012B (zh) | 2016-02-03 |
Family
ID=50561078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310723889.1A Expired - Fee Related CN103768012B (zh) | 2013-12-24 | 2013-12-24 | 一种姜黄素脂质纳米粒悬浮液或纳米粒的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103768012B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106334196A (zh) * | 2016-10-21 | 2017-01-18 | 新乡医学院 | 双亲性羟丙基‑β‑环糊精纳米药物载体及其载药纳米粒子的制备方法 |
CN106606419A (zh) * | 2015-10-26 | 2017-05-03 | 北京化工大学 | 一种应用微通道技术制备难溶性药物纳米分散体的方法 |
CN107028913A (zh) * | 2017-06-12 | 2017-08-11 | 浙江工业大学 | 一种聚己内酯‑环糊精给药纳米粒的制备方法 |
CN107049944A (zh) * | 2017-05-14 | 2017-08-18 | 辽宁大学 | 一种可实现索拉非尼和姜黄素同时给药的聚合物胶束及其制备方法 |
CN107049990A (zh) * | 2017-06-12 | 2017-08-18 | 浙江工业大学 | 一种聚三己内酯‑丙三酸给药纳米粒的微通道制备方法 |
CN107243002A (zh) * | 2017-06-12 | 2017-10-13 | 浙江工业大学 | 一种聚四己内酯‑季戊四醇给药纳米粒的制备方法 |
CN107744514A (zh) * | 2017-08-14 | 2018-03-02 | 浙江工业大学 | 一种具有酶靶向性的星状给药纳米粒的制备方法 |
CN107744515A (zh) * | 2017-08-14 | 2018-03-02 | 浙江工业大学 | 一种具有酶靶向性和缓控释特性的给药纳米粒的制备方法 |
CN110652503A (zh) * | 2019-10-21 | 2020-01-07 | 广州中医药大学(广州中医药研究院) | 一种姜黄素纳米粒子及其制备方法与应用 |
CN112461716A (zh) * | 2020-10-29 | 2021-03-09 | 四川省肿瘤医院 | 大黄素联合索拉非尼的纳米制剂对HepG2增殖的抑制验证方法 |
CN112691625A (zh) * | 2020-12-02 | 2021-04-23 | 中国科学院大连化学物理研究所 | 一种纳米药物的超声微反应器制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101711740A (zh) * | 2009-12-18 | 2010-05-26 | 苏州大学 | 一种溃疡性结肠炎靶向姜黄素纳米粒的制备方法 |
-
2013
- 2013-12-24 CN CN201310723889.1A patent/CN103768012B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101711740A (zh) * | 2009-12-18 | 2010-05-26 | 苏州大学 | 一种溃疡性结肠炎靶向姜黄素纳米粒的制备方法 |
Non-Patent Citations (1)
Title |
---|
张颂红: "微通道内固体脂质纳米粒的成型与传质机理研究", 《中国博士学位论文全文数据库工程科技Ⅰ辑》, no. 4, 15 April 2012 (2012-04-15), pages 016 - 29 * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106606419A (zh) * | 2015-10-26 | 2017-05-03 | 北京化工大学 | 一种应用微通道技术制备难溶性药物纳米分散体的方法 |
CN106606419B (zh) * | 2015-10-26 | 2019-10-18 | 北京化工大学 | 一种应用微通道技术制备难溶性药物纳米分散体的方法 |
CN106334196B (zh) * | 2016-10-21 | 2018-11-16 | 新乡医学院 | 双亲性羟丙基-β-环糊精纳米药物载体及其载药纳米粒子的制备方法 |
CN106334196A (zh) * | 2016-10-21 | 2017-01-18 | 新乡医学院 | 双亲性羟丙基‑β‑环糊精纳米药物载体及其载药纳米粒子的制备方法 |
CN107049944B (zh) * | 2017-05-14 | 2020-04-10 | 辽宁大学 | 一种可实现索拉非尼和姜黄素同时给药的聚合物胶束及其制备方法 |
CN107049944A (zh) * | 2017-05-14 | 2017-08-18 | 辽宁大学 | 一种可实现索拉非尼和姜黄素同时给药的聚合物胶束及其制备方法 |
CN107049990B (zh) * | 2017-06-12 | 2020-02-21 | 浙江工业大学 | 一种聚三己内酯-丙三酸给药纳米粒的微通道制备方法 |
CN107049990A (zh) * | 2017-06-12 | 2017-08-18 | 浙江工业大学 | 一种聚三己内酯‑丙三酸给药纳米粒的微通道制备方法 |
CN107243002A (zh) * | 2017-06-12 | 2017-10-13 | 浙江工业大学 | 一种聚四己内酯‑季戊四醇给药纳米粒的制备方法 |
CN107028913A (zh) * | 2017-06-12 | 2017-08-11 | 浙江工业大学 | 一种聚己内酯‑环糊精给药纳米粒的制备方法 |
CN107243002B (zh) * | 2017-06-12 | 2020-04-24 | 浙江工业大学 | 一种聚四己内酯-季戊四醇给药纳米粒的制备方法 |
CN107028913B (zh) * | 2017-06-12 | 2020-04-24 | 浙江工业大学 | 一种聚己内酯-环糊精给药纳米粒的制备方法 |
CN107744515A (zh) * | 2017-08-14 | 2018-03-02 | 浙江工业大学 | 一种具有酶靶向性和缓控释特性的给药纳米粒的制备方法 |
CN107744514A (zh) * | 2017-08-14 | 2018-03-02 | 浙江工业大学 | 一种具有酶靶向性的星状给药纳米粒的制备方法 |
CN107744514B (zh) * | 2017-08-14 | 2020-06-30 | 浙江工业大学 | 一种具有酶靶向性的星状给药纳米粒的制备方法 |
CN110652503A (zh) * | 2019-10-21 | 2020-01-07 | 广州中医药大学(广州中医药研究院) | 一种姜黄素纳米粒子及其制备方法与应用 |
CN112461716A (zh) * | 2020-10-29 | 2021-03-09 | 四川省肿瘤医院 | 大黄素联合索拉非尼的纳米制剂对HepG2增殖的抑制验证方法 |
CN112461716B (zh) * | 2020-10-29 | 2024-03-22 | 四川省肿瘤医院 | 大黄素联合索拉非尼的纳米制剂对HepG2增殖的抑制验证方法 |
CN112691625A (zh) * | 2020-12-02 | 2021-04-23 | 中国科学院大连化学物理研究所 | 一种纳米药物的超声微反应器制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103768012B (zh) | 2016-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103768012B (zh) | 一种姜黄素脂质纳米粒悬浮液或纳米粒的制备方法 | |
Liu et al. | Core/shell nanocomposites produced by superfast sequential microfluidic nanoprecipitation | |
Zhang et al. | Microfluidic methods for fabrication and engineering of nanoparticle drug delivery systems | |
Feng et al. | Microfluidics-mediated assembly of functional nanoparticles for cancer-related pharmaceutical applications | |
Wang et al. | Facile synthesis of uniform virus-like mesoporous silica nanoparticles for enhanced cellular internalization | |
Su et al. | High biocompatible ZIF-8 coated by ZrO2 for chemo-microwave thermal tumor synergistic therapy | |
Karnik et al. | Microfluidic platform for controlled synthesis of polymeric nanoparticles | |
Liu et al. | A mini review of nanosuspensions development | |
Fang et al. | Large-scale synthesis of lipid–polymer hybrid nanoparticles using a multi-inlet vortex reactor | |
EP2932978A1 (en) | Application of silicon dioxide aerogel in pharmacy | |
Chen et al. | Preparation and characterization of a nanostructured lipid carrier for a poorly soluble drug | |
Fabozzi et al. | Design of functional nanoparticles by microfluidic platforms as advanced drug delivery systems for cancer therapy | |
Zhang et al. | Microfluidics for nano-drug delivery systems: from fundamentals to industrialization | |
Dev et al. | Microfluidic fabrication of cationic curcumin nanoparticles as an anti-cancer agent | |
Yu et al. | Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique | |
Zhu et al. | Rapid production of single-and multi-compartment polymeric microcapsules in a facile 3D microfluidic process for magnetic separation and synergistic delivery | |
Fan et al. | Nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment | |
CN103285411A (zh) | 一种基于聚乳酸羟基乙酸共聚物的磁性载药空心微球的制备方法 | |
WO2019007019A1 (zh) | 一种补骨脂素聚合物纳米粒制剂以及制备方法 | |
US20160158383A1 (en) | Method and device for manufacturing polymer particles containing a therapeutic material | |
Pandita et al. | Albumin-coated mesoporous silica nanoparticles of docetaxel: preparation, characterization, and pharmacokinetic evaluation | |
Nair et al. | Poly (lactide-co-glycolide)–laponite–F68 nanocomposite vesicles through a single-step double-emulsion method for the controlled release of doxorubicin | |
Shen et al. | A timescale-guided microfluidic synthesis of tannic acid-FeIII network nanocapsules of hydrophobic drugs | |
Caggiano et al. | Sequential Flash NanoPrecipitation for the scalable formulation of stable core-shell nanoparticles with core loadings up to 90% | |
CN102525936B (zh) | 一种复方盐酸表柔比星plga纳米粒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170925 Address after: 310000 modern home building, Xiacheng District, Zhejiang City, Hangzhou province 1101 Patentee after: Zhejiang sigma Biological Technology Co.,Ltd. Address before: 310014 Zhejiang province Hangzhou City Wenhui Road No. 42 building, 1101 West Modern Home Office Patentee before: ZHEJIANG KAISHENG TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210107 Address after: 321100 No.85, Zhiyuan Road, Jiangnan Park, Lanxi Economic Development Zone, Jinhua City, Zhejiang Province Patentee after: Zhejiang Jia Tai Technology Co.,Ltd. Address before: 310000 modern real estate building 1101, Xiacheng District, Hangzhou City, Zhejiang Province Patentee before: Zhejiang sigma Biological Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160203 |